Genetics of Diagnostic and staging evaluation of lung cancer

(usually just in adv/metastatic disease):

  • EGFR (include in stage IIA-IIIB),
  • ALK,
  • ROS1,
  • MET,
  • KRAS,
  • RET,
  • BRAF,
  • NTRK fusion

for all non-squamous disease (incidence lower in SCC but still consider testing); PD-L1 expression